NSEAnalysts/Institutional Investor Meet/Con. Call Updates6 Jul 2026 · 6 Jul 2026, 05:09 pm
Analysts/Institutional Investor Meet/Con. Call Updates
Amanta Healthcare Limited · AMANTA
✦ AI Summary
Amanta Healthcare Limited has informed the Exchange about the schedule of an investor/analyst meeting on July 9, 2026, with ValPro Capital.
Analysis Scores
Earnings Impact5/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Amanta Healthcare Limited has informed the Exchange about Schedule of meet
Attachments (1)
📄pdf
Download →
AMANTA_06072026170908_Intimation_of_schedule_of_Investor_Meet.pdf
View document text
Registered & Corporate Office:
AMANTA HEALTHCARE LIMITED
8th Floor, Shaligram Corporates, CJ Marg,
Ambli, Ahmedabad–380058, Gujarat, INDIA.
Tel.: 079 – 67777600
Email: info@amanta.co.in
Website: www.amanta.co.in
CIN: L24139GJ1994PLC023944
Date: July 6, 2026
To, To,
Sr. General Manager Sr. General Manager
Listing Department National Stock Exchange of India Limited
BSE Limited Exchange Plaza, C-1, Block G
Phiroze Jeejeebhoy Towers, Bandra Kurla Complex
Dalal Street, Mumbai – 400 001. Bandra (E), Mumbai – 400 051.
Scrip Code: 544502 Trading Symbol: AMANTA
Dear Sir / Madam,
Sub: Intimation of Schedule of Investor / Analyst Meeting under the SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015.
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and
Disclosure Requirements), Regulations, 2015, the schedule of Investor / Analyst Meeting with the
Company is as below:
Date Particulars of Investor Time Type of Meeting
Thursday, July 9, 2026 ValPro Capital 05:00 P.M. Virtual
Notes:
i. The above schedule may undergo changes due to exigencies on the part of the Investor of the
Company.
ii. No unpublished price sensitive information pertaining to the Company will be shared at the
meet with investor.
You are requested to take the same on record.
Thanking you,
Yours faithfully,
FOR, AMANTA HEALTHCARE LIMITED
NIKHITA DINODIA
COMPANY SECRETARY & COMPLIANCE OFFICER
Factory: 876, N.H. No. 8, Hariyala, Kheda – 387411, Gujarat, India. Tel 2694287700 Fax 2694287720